influenza vaccine quadrivalent oral

An oral quadrivalent influenza vaccine would be a **vaccine** intended to induce protective immune responses against four seasonal influenza virus components, typically two influenza A strains and two influenza B lineages or equivalent contemporary B components. However, the queried product name is not identifiable as a specific marketed or clinically well-defined human influenza vaccine formulation in major regulatory and clinical-trial sources. Currently recognized quadrivalent influenza vaccines are predominantly injectable inactivated or recombinant products, or the live attenuated **intranasal** product FluMist Quadrivalent; an established **oral** quadrivalent influenza vaccine could not be confirmed. Because no specific product, developer, composition, platform, or development program could be tied with confidence to this exact name, the entry is best treated as a non-specific or likely incorrect formulation description rather than a validated distinct drug entity.

Other names

influenza vaccine quadrivalent oraloral quadrivalent influenza vaccine